KAPVAY (CLONIDINE HYDROCHLORIDE) — FDA Approval NDA022331 (CONCORDIA PHARMS INC)
KAPVAY (CLONIDINE HYDROCHLORIDE) — FDA Approval NDA022331 (CONCORDIA PHARMS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: KAPVAY; Active ingredients: CLONIDINE HYDROCHLORIDE; Application number: NDA022331.
| Brand name | KAPVAY |
|---|---|
| Active ingredients | CLONIDINE HYDROCHLORIDE |
| Application number | NDA022331 |
| Sponsor | CONCORDIA PHARMS INC |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 20090929 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →